Jamp-Metformin Product Recall (2020-03-10)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
A. Jamp-Metformin 500 mg tablet
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| X20385, X20386, X19224, X19225, X19226 | - Recalling Firm
- JAMP Pharma Corporation
- 1310 Nobel Street
- Boucherville
- J4B 5H3
- Quebec
- CANADA
- Marketing Authorization Holder
- JAMP Pharma Corporation
- 1310 Nobel Street
- Boucherville
- J4B 5H3
- Quebec
- CANADA
| B. Jamp-Metformin 850 mg tablet | DIN 02380218 | tablet | Metformin hydrochloride 850 mg |
| X20283, X20284, X20286, X20287, X20288, Y00225, Y00226, Y00227, Y00228, Y00229, Y00230, Y00231, Y00232, Y01573, Y01574, Y01575, Y01576, Y01577, Y01578, Y01579, Y01580 | - Recalling Firm
- JAMP Pharma Corporation
- 1310 Nobel Street
- Boucherville
- J4B 5H3
- Quebec
- CANADA
- Marketing Authorization Holder
- JAMP Pharma Corporation
- 1310 Nobel Street
- Boucherville
- J4B 5H3
- Quebec
- CANADA
| A. Jamp-Metformin 500 mg tablet | DIN 02380196 | tablet | Metformin hydrochloride 500 mg |
A. Jamp-Metformin 500 mg tablet
B. Jamp-Metformin 850 mg tablet
Affected lots may contain N-nitrosodimethylamine (NDMA) above the interim acceptable concentration limit.